Gilde Healthcare portfolio company Eetgemak joins forces with TotaalVERS to become the leading integrated healthcare foodservice provider - Gilde Healthcare

Gilde Healthcare portfolio company Eetgemak joins forces with TotaalVERS to become the leading integrated healthcare foodservice provider

5 juli 2024
Katwijk & Spijkenisse (the Netherlands)

Combining TotaalVERS and Eetgemak will form a leading end-to-end foodservice provider*, offering a wide range of convenience meals, ingredients and groceries to the healthcare sector. The partnership emphasizes commitment to quality, service, and innovation in the healthcare market. Strengthening their joint position will further elevate service levels and product offerings of both companies. The combination aims to maintain current service offerings and respect existing organizations, brands and partners. Integration will be done carefully, with the existing management teams and no changes to operations in Katwijk and Spijkenisse.

Ronald Holtzer, CEO of EetgemakWe are excited to join forces with TotaalVERS, together we create a full-service “one stop shop” for our current and future customers.”

Ronald van der Leer, CEO of TotaalVERS: “This partnership marks an important milestone in our history and reaffirms our commitment to quality, service and innovation in the healthcare market and other channels.” 

*The combination of TotaalVERS and Eetgemak is subject to approval from the ACM

About TotaalVERS
Founded in 2004 in Spijkenisse, TotaalVERS is an integrated producer and supplier of convenience meals, ingredients and groceries. Praised for its high service level, the company serves care & cure clients in the South-West of the Netherlands. The company has a state-of-the-art production and warehouse facility housing c. 125 employees. For more information, visit the company’s website at www.totaalvers.nl

About Eetgemak
Eetgemak is a leading producer and supplier of fresh, made-to-order meals, meal components and dietary meals. The organization supplies the care & cure sector in the Netherlands with over 40k meals per day. Gilde invested in the company in 2019 and is supporting Eetgemak in the expansion of its market position, through growth in existing and new markets. For more information, visit the company’s website at www.eetgemakgroep.nl

About Gilde Healthcare
Gilde Healthcare is a specialized healthcare investor managing over €2.6 billion across two fund strategies: Private Equity and Venture&Growth. The Private Equity fund of Gilde Healthcare participates in profitable lower mid-market healthcare companies based in North-Western Europe. The Venture&Growth fund of Gilde Healthcare invests in fast growing companies active in digital health, medtech and therapeutics, based in Europe and North America. For more information, visit the company’s website at www.gildehealthcare.com

 

Gilde Healthcare company SpliceBio announces first patient dosed in Phase 1/2 ASTRA study of SB-007, a Dual-AAV Gene Therapy for Stargardt Disease

SB-007 addresses the root cause of Stargardt disease with the potential to treat all patients across all ABCA4 mutations SB-007 is the first dual AAV gene therapy in clinical development for Stargardt disease   SpliceBio,...
13 maart 2025

Gilde Healthcare participates in $65 Million financing of Microtransponder to enhance Vivistim adoption for Chronic Stroke Recovery

MicroTransponder®, Inc, today announces a $65 million Series F financing round. MicroTransponder is a fast growing commercial stage stroke company with the FDA-approved Vivistim® Paired VNS™ System. Gilde Healthcare joins the round as new investor,...
12 maart 2025

Gilde Healthcare Company Purespring Therapeutics appoints Haseeb Ahmad as Chief Executive Officer

Purespring Therapeutics, a pioneering company focused on transforming the treatment of kidney diseases, today announces the appointment of Haseeb Ahmad as its Chief Executive Officer and member of the Board of Directors effective immediately. Haseeb...
12 maart 2025